It is well known that myo-inositol (MI) and D-chiro-inositol (DCI) are insulin-sensitizing agents, and MI is of proven utility in polycystic ovary syndrome (PCOS). In addition, MI plays a pivotal role in the physiology of reproduction, and has beneficial effects on the development of oocytes, spermatozoa, and embryos. By contrast, DCI has little effect on spermatozoa, but high concentrations in the ovary can negatively affect the quality of oocytes and the blastocyst. Overall, the evidence in the literature supports the beneficial effects of MI in both female and male reproduction, warranting clinical use of MI in assisted reproductive treatment (ART).

Breakthroughs in the Use of Inositols for Assisted Reproductive Treatment (ART) / Facchinetti, F.; Espinola, M. S. B.; Dewailly, D.; Ozay, A. C.; Prapas, N.; Vazquez-Levin, M.; Wdowiak, A.; Unfer, V.; Appetecchia, M.; Aragona, C.; Bertelli, M.; Bevilacqua, A.; Bizzarri, M.; Cavalli, P.; Copp, A.; D'Anna, R.; Greene, N.; Marin, I. H.; Kamenov, Z. A.; Kandaraki, E.; Diamanti-Kandarakis, E.; Lagana, A. S.; Monastra, G.; Oliva, M. M.; Nestler, J. E.; Papalou, O.; Pkhaladze, L.; Porcaro, G.; Soulage, C. O.; Stringaro, A.. - In: TRENDS IN ENDOCRINOLOGY AND METABOLISM. - ISSN 1043-2760. - 31:8(2020), pp. 570-579. [10.1016/j.tem.2020.04.003]

Breakthroughs in the Use of Inositols for Assisted Reproductive Treatment (ART)

Facchinetti F.;Unfer V.;Bizzarri M.;
2020

Abstract

It is well known that myo-inositol (MI) and D-chiro-inositol (DCI) are insulin-sensitizing agents, and MI is of proven utility in polycystic ovary syndrome (PCOS). In addition, MI plays a pivotal role in the physiology of reproduction, and has beneficial effects on the development of oocytes, spermatozoa, and embryos. By contrast, DCI has little effect on spermatozoa, but high concentrations in the ovary can negatively affect the quality of oocytes and the blastocyst. Overall, the evidence in the literature supports the beneficial effects of MI in both female and male reproduction, warranting clinical use of MI in assisted reproductive treatment (ART).
2020
15-mag-2020
31
8
570
579
Breakthroughs in the Use of Inositols for Assisted Reproductive Treatment (ART) / Facchinetti, F.; Espinola, M. S. B.; Dewailly, D.; Ozay, A. C.; Prapas, N.; Vazquez-Levin, M.; Wdowiak, A.; Unfer, V.; Appetecchia, M.; Aragona, C.; Bertelli, M.; Bevilacqua, A.; Bizzarri, M.; Cavalli, P.; Copp, A.; D'Anna, R.; Greene, N.; Marin, I. H.; Kamenov, Z. A.; Kandaraki, E.; Diamanti-Kandarakis, E.; Lagana, A. S.; Monastra, G.; Oliva, M. M.; Nestler, J. E.; Papalou, O.; Pkhaladze, L.; Porcaro, G.; Soulage, C. O.; Stringaro, A.. - In: TRENDS IN ENDOCRINOLOGY AND METABOLISM. - ISSN 1043-2760. - 31:8(2020), pp. 570-579. [10.1016/j.tem.2020.04.003]
Facchinetti, F.; Espinola, M. S. B.; Dewailly, D.; Ozay, A. C.; Prapas, N.; Vazquez-Levin, M.; Wdowiak, A.; Unfer, V.; Appetecchia, M.; Aragona, C.; Bertelli, M.; Bevilacqua, A.; Bizzarri, M.; Cavalli, P.; Copp, A.; D'Anna, R.; Greene, N.; Marin, I. H.; Kamenov, Z. A.; Kandaraki, E.; Diamanti-Kandarakis, E.; Lagana, A. S.; Monastra, G.; Oliva, M. M.; Nestler, J. E.; Papalou, O.; Pkhaladze, L.; Porcaro, G.; Soulage, C. O.; Stringaro, A.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1207965
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 32
social impact